Novavax shares fall on RSV, NanoFlu vaccine updates
December 19, 2017 at 14:50 PM EST
Novavax officials said they're on pace to submit biologics license application with the U.S. Food and Drug Administration by late 2019 — but investors clearly harbor concerns.
